Cantor Fitzgerald Has Weak Estimate for ITCI FY2025 Earnings
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) – Equities researchers at Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for Intra-Cellular Therapies in a research report issued on Monday, February 24th. Cantor Fitzgerald analyst C. Duncan now anticipates that the biopharmaceutical company will post earnings per share of ($0.51) for the year, down […]
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) – Equities researchers at Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for Intra-Cellular Therapies in a research report issued on Monday, February 24th. Cantor Fitzgerald analyst C. Duncan now anticipates that the biopharmaceutical company will post earnings per share of ($0.51) for the year, down […]
